ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > Envelope protein

Envelope protein

概要

Name:Recombinant envelope protein
Target Synonym:env,Submitted name: Recombinant envelope protein,Viral Envelope Proteins
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
ENN-C5128 SARS-CoV-2 SARS-CoV-2 (COVID-19) Envelope protein, GST,His Tag
ENN-C5128-structure
ENN-C5128-sds
ACRO Quality

Synonym Name

Envelope protein,Env polyprotein,Envelope glycoprotein,env

Background

The SARS-CoV-2 is composed of a double-layered lipid envelope, including Spike glycoprotein (S), Envelope protein (E), Membrane glycoprotein (M), and Nucleocapsid protein (Nucleocapsid protein, N). Among them, The amino acid sequence of the SARS-CoV-2 envelope protein is 95% identical of the SARS envelope protein.

Clinical and Translational Updates

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tecovirimat ST-246; SIGA-246 Approved Siga Technologies Inc Tpoxx United Kingdom Monkeypox; Smallpox; Cowpox Siga Technologies Inc 2018-07-13 Smallpox; Cowpox; Vaccinia; Poxviridae Infections; Monkeypox Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Targeting HIV-1 Env gp140 antibodies Phase 2 Clinical National Institute Of Allergy And Infectious Diseases (Niaid) HIV Infections Details
PGDM-1400 PGDM-1400 Phase 1 Clinical International Aids Vaccine Initiative HIV Infections Details
Temelimab GNN-001; GENHP-01; GNbAC-1 Phase 2 Clinical Geneuro Sa Diabetes Mellitus, Type 1; Multiple Sclerosis, Relapsing-Remitting; Coronavirus Disease 2019 (COVID-19); Multiple Sclerosis Details

This web search service is supported by Google Inc.

totopphone